What's in Aurinia Pharmaceuticals Inc.'s pipeline?

Aurinia Pharmaceuticals Inc. has 3 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Aurinia Pharmaceuticals Inc.'s portfolio?

Top competitors by shared drug class: Albert Einstein Healthcare Network, Allergan, Andrew B Adams, Armando Torres Ramírez, Assistance Publique - Hôpitaux de Paris.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aurinia-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Aurinia Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aurinia Pharmaceuticals Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
LUPKYNIS	LUPKYNIS	marketed	Calcineurin inhibitor	Calcineurin (via cyclophilin binding)	Immunology / Nephrology

Therapeutic area mix

Immunology / Nephrology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Albert Einstein Healthcare Network · 1 shared drug class
Allergan · 1 shared drug class
Andrew B Adams · 1 shared drug class
Armando Torres Ramírez · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Astellas Pharma China, Inc. · 1 shared drug class
Astellas Pharma Europe Ltd. · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Aurinia Pharmaceuticals Inc.:

Cite this brief

Drug Landscape (2026). Aurinia Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aurinia-pharmaceuticals-inc. Accessed 2026-05-17.